1492 Capital Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Buy
487,369
+163,350
+50% +$3.14M 3.43% 3
2026
Q1
$5.71M Sell
324,019
-846
-0.3% -$17K 2.17% 10
2025
Q4
$6.42M Buy
324,865
+124,143
+62% +$2.23M 2.46% 9
2025
Q3
$3.5M Buy
200,722
+114,622
+133% +$1.7M 1.42% 27
2025
Q2
$1.21M Sell
86,100
-22,583
-21% -$364K 0.56% 64
2025
Q1
$2.02M Buy
108,683
+13
+0% +$194 1.09% 35
2024
Q4
$1.22M Buy
108,670
+36,755
+51% +$430K 0.58% 54
2024
Q3
$850K Buy
+71,915
New +$680K 0.42% 53

Other funds holding ALHC

1492 Capital Management's ALHC Position: Q2 2026 in Review

1492 Capital Management increased its Alignment Healthcare (ALHC) stake by 50% in Q2 2026, buying an estimated $3.14M and bringing the position to 487,369 shares worth $11.6M. The position accounts for 3.43% of the portfolio, ranked #3.

1492 Capital Management first reported a position in ALHC in Q3 2024 and has held it in 8 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • 1492 Capital Management held 487,369 shares of Alignment Healthcare worth $11.6M as of Q2 2026.
  • 1492 Capital Management bought 163,350 Alignment Healthcare shares in Q2 2026, an estimated $3.14M.
  • Alignment Healthcare made up 3.43% of 1492 Capital Management's portfolio in Q2 2026, its #3 holding.
  • 1492 Capital Management first reported a position in Alignment Healthcare in Q3 2024 and has held it in 8 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on 1492 Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.